Posts By Alex
-
584Wire StoriesIt�s all Treat and No Trick at Juicy Stakes Casino This Halloween
MELBOURNE, Australia–(BUSINESS WIRE)–Are you looking for a whole lot of treat and not so much trick this Halloween? If so, Juicy Stakes...
-
663Wire Stories
Coupang and Payoneer Partner to Empower Millions of Sellers to Tap into One of the World�s Largest eCommerce Markets
South Korean consumers get an even more diverse range of products from trusted sellers around the world NEW YORK–(BUSINESS WIRE)–Payoneer (NASDAQ: PAYO),...
-
542Wire Stories
New BISTelligence Spin-Off Focused on Manufacturing AI Excellence
Two New Divisions to Drive mAI Consulting Services and AI Asset Performance Management Products SAN JOSE, Calif.–(BUSINESS WIRE)–BISTelligence, a leading supplier of...
-
873Wire Stories
GC Labs Introduces the Microbiology Total Laboratory Automation System for the First Time in Korea
Improving efficiency and accuracy for microbiology tests YONGIN, South Korea–(BUSINESS WIRE)–GC Labs (CEO Eun-hee Lee), the leading clinical diagnostics company in Korea,...
-
639Wire Stories
Rare Element Resources Provides Update on Process for Potential Rights Offering
LITTLETON, Colo.–(BUSINESS WIRE)–Rare Element Resources Ltd. (the �Company� or �RER�) (OTCQB: REEMF) is pleased to provide an update regarding the pending launch...
-
551Wire Stories
Rare Element Resources Provides Update on Process for Potential Rights Offering
LITTLETON, Colo.–(BUSINESS WIRE)–Rare Element Resources Ltd. (the �Company� or �RER�) (OTCQB: REEMF) is pleased to provide an update regarding the pending launch...
-
576Wire Stories
Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA� (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer
TROPION-Lung08 phase 3 trial to evaluate the Daiichi Sankyo and AstraZeneca TROP2 directed ADC with Merck & Co., Inc., Kenilworth, NJ., USA�s...
-
653Wire Stories
Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA� (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer
TROPION-Lung08 phase 3 trial to evaluate the Daiichi Sankyo and AstraZeneca TROP2 directed ADC with Merck & Co., Inc., Kenilworth, NJ., USA�s...
-
609Wire Stories
CANbridge Pharmaceuticals Enters into Exclusive Worldwide Research Collaboration and Licensing Agreement with Scriptr Global for Stitchr� RNA Assembly Technology to Develop Gene Therapy Product Targeting Dystrophinopathies
CANbridge to Have Exclusive Worldwide Rights to Product BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical...
-
513Wire Stories
Empowering Blockchain Development, the New Crypto Mission of ViaBTC Capital
HONG KONG–(BUSINESS WIRE)–Recently, as the crypto market gradually rebounds, the expected latter half of the bull market has arrived. With a dazzling...
